Yeast cell-cell communication of overcrowding and nutrient limitation: novel signalling systems and their impact on fermentation. The project will investigate known and novel signalling molecules that allow communication between yeast cells and impact on fermentation dynamics, specifically in a nutrient-depleted environment. The mechanisms by which these molecules exert their effect will be defined using a systems biology approach that integrates many analyses and data sets.
Sustainable dollar notes and other polypropylenes from bioderived feedstocks. Fossil fuels provide us with the essential chemicals for our life style. The chemical industry recognizes limited supply and a need to reduce carbon emissions. Microbes are able to supply green chemicals (e.g. bio-ethanol), but efficiencies are often low. This project will develop microbes for the fermentative production of plastics from cane sugar.
Yield improvement in large-scale bubble column fermenters. For companies operating in the global marketplace, yield differences of a few percent can be critically important. Improving yeast fermentation yield requires major advances in modelling the bubble size distribution and how this impacts micro- and macro-scale mixing. Model-based knowledge transfer via full-scale plant trials is a key outcome.
New fermentation and purification production technologies for menaquinone-7 for promoting bone and cardiovascular health. We will develop a significantly more cost-efficient and environmentally friendly process for the production of vitamin K (menaquinone-7, or MK7) to manufacture food supplements for humans and animals. MK7 will increase bone regeneration and minimise the risk of cardiovascular disease. It has the potential to reduce the costs of these conditions for the community, and to incre ....New fermentation and purification production technologies for menaquinone-7 for promoting bone and cardiovascular health. We will develop a significantly more cost-efficient and environmentally friendly process for the production of vitamin K (menaquinone-7, or MK7) to manufacture food supplements for humans and animals. MK7 will increase bone regeneration and minimise the risk of cardiovascular disease. It has the potential to reduce the costs of these conditions for the community, and to increase the quality of life for Australia's ageing population. Orthopaedic diseases are also a major veterinary issue, and our advance should make MK7 a more widely used available supplementary food for animals such as horses and dogs. Read moreRead less